Teachers Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History

Teachers Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$3.75M	Buy	96,044 +21,901	+30%	+$628K	﹤0.01%	1591
2018 Q4	$1.58M	Buy	74,143 +8,473	+13%	+$219K	﹤0.01%	1967
2018 Q3	$2.6M	Buy	65,670 +1,470	+2%	+$54.8K	﹤0.01%	1826
2018 Q2	$2.45M	Buy	64,200 +30,876	+93%	+$1.14M	﹤0.01%	1835
2018 Q1	$1M	Buy	33,324 +2,977	+10%	+$101K	﹤0.01%	2204
2017 Q4	$948K	Buy	30,347 +3,421	+13%	+$93.9K	﹤0.01%	2259
2017 Q3	$754K	Hold	26,926	–	–	﹤0.01%	2389
2017 Q2	$515K	Buy	26,926 +20,841	+342%	+$333K	﹤0.01%	2582
2017 Q1	$104K	Hold	6,085	–	–	﹤0.01%	2973
2016 Q4	$111K	Hold	6,085	–	–	﹤0.01%	2999
2016 Q3	$108K	Buy	+6,085	New	+$92.3K	﹤0.01%	2995

Other funds holding BOLD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Teachers Advisors's BOLD Position: Q1 2019 in Review

Teachers Advisors increased its Audentes Therapeutics, Inc (BOLD) stake by 30% in Q1 2019, buying an estimated $628K and bringing the position to 96,044 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1591.

Teachers Advisors first reported a position in BOLD in Q3 2016 and has held it in 11 quarters since. 139 funds tracked by Wall St. Rank hold BOLD as of Q1 2019.

Teachers Advisors held 96,044 shares of Audentes Therapeutics, Inc worth $3.75M as of Q1 2019.
Teachers Advisors bought 21,901 Audentes Therapeutics, Inc shares in Q1 2019, an estimated $628K.
Audentes Therapeutics, Inc made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1591 holding.
Teachers Advisors first reported a position in Audentes Therapeutics, Inc in Q3 2016 and has held it in 11 quarters since.
139 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.